ZPHC Retatrutide Pen 60mg
| Pack: | Price per Item | Total |
| $360.00 | $360.00 | |
| $350.00 | $1 750.00 |
ZPHC Retatrutide Pen 60mg
ZPHC Retatrutide Pen 60mg is a pen-format product labeled as containing 60mg of retatrutide and is listed under Zhengzhou Pharmaceuticals Co., Ltd. (ZPHC). Unlike vial-based products, this listing is specifically presented in a pen format. Retatrutide is an investigational peptide being studied as a triple hormone receptor agonist, targeting the GIP, GLP-1, and glucagon receptors. The product's combination of ZPHC branding, 60mg labeled quantity, retatrutide, and pen presentation distinguishes this listing from other retatrutide products with different quantities or formats.
Product Details
| Detail | Information |
|---|---|
| Product Name | ZPHC Retatrutide Pen |
| Active Ingredient | Retatrutide |
| Manufacturer / Brand | Zhengzhou Pharmaceuticals Co., Ltd. (ZPHC) |
| Strength / Labeled Quantity | 60mg |
| Dosage Form | Pen |
| Package Size | |
| Product Category | Retatrutide |
About ZPHC Retatrutide Pen 60mg
ZPHC Retatrutide Pen 60mg is a retatrutide product presented in a pen format and listed under Zhengzhou Pharmaceuticals Co., Ltd. The product page identifies the formulation as 60mg, although it does not currently provide enough information to verify the concentration, total liquid volume, or number of individual pens supplied.
Retatrutide is an investigational peptide developed around simultaneous activity at three metabolic hormone receptors: GIP, GLP-1, and glucagon receptors. This triple-agonist mechanism distinguishes retatrutide from compounds targeting fewer receptor pathways.
For this particular listing, the most useful identifying terms are ZPHC Retatrutide Pen, ZPHC Retatrutide 60mg, Retatrutide ZPHC, and ZPHC Reta 60mg. These aren't arbitrary SEO additions: the URL-specific GSC report shows Google already ranking this page prominently for these exact product variations.
The current description makes treatment-oriented claims that should be updated to clearly communicate retatrutide's investigational status rather than presenting it as an approved treatment.
Key Features
-
Active ingredient: Retatrutide
-
Brand: ZPHC / Zhengzhou Pharmaceuticals Co., Ltd.
-
Labeled quantity: 60mg
-
Product format: Pen
-
Product category: Retatrutide
-
Package quantity/concentration: Not specified on the current product page and should be verified before adding
Retatrutide Information
Retatrutide is an investigational peptide and triple receptor agonist targeting the GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors.
It has been studied in clinical trials for obesity and metabolic conditions. However, retatrutide remains investigational and should not be described as an approved obesity or diabetes medication.
Terms such as ZPHC retatrutide, retatrutide ZPHC, ZPHC retatrutide 60mg, and retatrutide 60mg ZPHC refer to the manufacturer/brand and labeled quantity associated with this particular listing.
The “60mg” specification alone should not be interpreted as a concentration such as mg/mL. The current product page does not provide sufficient information to establish concentration or liquid volume, so those specifications should not be inferred.
Product Information & Safety
Retatrutide is an investigational drug and is not currently FDA-approved. It remains under clinical investigation for obesity and related metabolic conditions.
Because retatrutide has not received regulatory approval, claims describing it as an established “treatment” should be avoided. Safety, contraindications, interactions, and long-term effects continue to be evaluated through clinical research.
This page provides general product-identification information and should not be interpreted as medical advice, dosing guidance, or instructions for using investigational compounds.
Frequently Asked Questions
What is ZPHC Retatrutide Pen 60mg?
It is a pen-format product listed under Zhengzhou Pharmaceuticals Co., Ltd. (ZPHC) and labeled as Retatrutide 60mg.
What does ZPHC Retatrutide 60mg contain?
The product listing identifies retatrutide and a labeled quantity of 60mg. The current page does not provide sufficient information to verify its concentration or total liquid volume.
Who manufactures the ZPHC Retatrutide Pen?
The product is listed under Zhengzhou Pharmaceuticals Co., Ltd., commonly abbreviated as ZPHC.
Is ZPHC Retatrutide available as a pen?
This specific listing is named ZPHC Retatrutide Pen 60mg, distinguishing it from vial-based retatrutide listings.
What does ZPHC Retatrutide 60mg mean?
The product is labeled as 60mg Retatrutide. The current listing does not establish that 60mg represents an mg/mL concentration, so it should be described as the labeled quantity rather than concentration.
Is retatrutide FDA-approved?
No. Retatrutide remains an investigational drug and has not received FDA approval.
Product Reviews
Oliver C. — 5/5
“The pen looked exactly like the product shown on the site. The ZPHC branding and 60mg labeling were clear, and everything was securely sealed.”
Trevor G. — 4.5/5
“Really liked the pen format and overall presentation. It arrived intact, clearly labeled as Retatrutide 60mg, and matched the listing photos.”
Cameron S. — 5/5
“Product was exactly as described. The pen and packaging looked clean and professional, with the ZPHC and 60mg details clearly displayed.”
Blake R. — 4.5/5
“Very well-presented product. The pen was properly packaged and the labeling was easy to read. Everything about it matched the specifications shown online.”
